IMMP trade ideas
Taking This Chart out To Historic Levels With Pending CatalystIMMP has done great recovering from its last sell-off. But now it's back at a historic level of resistance that we clearly see on this chart right now. Upcoming potential catalyst this week will determine which direction it heads imo.
"Data from the TACTI-002 and INSIGHT-004 studies were published in abstracts on the 2021 ASCO Annual Meeting’s official website. Poster presentations with new and updated data not part of the abstracts become available on the site on June 4th. Considering that early data has shown potential in these treatments, it will be interesting to see if any further details are given at the ASCO this week."
Quote Source: Hot Penny Stocks To Buy On Robinhood With Upcoming Events This Week
IMMP per request....I made another mess.Ok So I put lines everywhere from all over the place and in the confusion of it all some areas started to have some confluence.....everything kept pointing to $6.80. I appreciate the request to take a look at this.
by iCantw84it
05.27.2021
Please Like Subscribe if you would like to see more of these.
Why $IMMP soared in December case studyFirst time an antigen presenting cell (APC) activator has shown an Overall Survival (OS) benefit in a randomised setting in metastatic breast cancer patients known to be insensitive to immune checkpoint inhibitor therapy
Promising and improving overall trend in OS in total population (based on approx. 60% of events): median survival benefit of +2.7 months from efti plus chemotherapy, compared to chemotherapy plus placebo.
Statistically significant OS benefit in efti group observed in pre-defined patient groups:
+7.1 months survival benefit (median of 21.9 vs. 14.8 months, nearly 50% longer) from efti with chemotherapy for patients under 65 years of age
+9.4 months survival benefit (median of 22.4 vs. 12.9 months, 74% longer) from efti with chemotherapy for patients with a low starting monocyte count
Statistically significant increase in CD8 T cells in patients treated with efti plus chemotherapy, correlated with prolonged OS, indicating pharmacodynamic activity and proof of concept of efti’s mode of action
Collection of OS data ongoing, with final data expected to be reported mid 2021
finance.yahoo.com
IMM 50% BREAK!!Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine.
Break out of ascending Triangle confirms, Targeting Supply @ 0.30
- Ascending Triangle Confirms
- 4th touch on Fib .236 breaks
- Measured move lines up with Supply
- RR 3.33:1
- Supply sitting in the Golden Pocket
- MACD still spread BUT starting to turn
- Ichimoku BULLISH and clear to run
Aware of the GAP at 0.15 - 0.165 but with more positive news it will stay unfilled for the foreseeable future. Also Bearish Divergence on the 4HR but again I do not think it is strong enough currently.
These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!